Induced resistance as a path to sustainable food security

As the climate crisis alters familiar growing conditions, we urgently need to find ways of protecting the world against famines.

Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit – Biotech Investments

EQS-News: Medios AG / Key word(s): Contract Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit 01.02.2024

February 2, 2024

Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

All doses of Novo Nordisk’s blockbuster diabetes and obesity treatments are listed as available on the Food and Drug Administration’s drug shortage list as of

October 30, 2024

Discovery of antibiotic lolamicin that targets deadly bacteria without harming gut microbiome

Researchers discovered lolamicin, a selective Gram-negative antibiotic, effective against multidrug-resistant pathogens while sparing the gut microbiome.

June 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.